HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 247 filers reported holding HAEMONETICS CORP in Q4 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $517,929,076 | +4.6% | 5,781,749 | -0.6% | 0.02% | +7.1% |
| Q2 2023 | $495,038,867 | +3.6% | 5,814,410 | +0.7% | 0.01% | 0.0% |
| Q1 2023 | $477,925,689 | +3.5% | 5,775,537 | -1.7% | 0.01% | 0.0% |
| Q4 2022 | $461,986,718 | +12.7% | 5,873,957 | +6.0% | 0.01% | 0.0% |
| Q3 2022 | $410,072,000 | +12.7% | 5,539,250 | -0.8% | 0.01% | +16.7% |
| Q2 2022 | $363,993,000 | -3.3% | 5,584,435 | -6.2% | 0.01% | +20.0% |
| Q1 2022 | $376,267,000 | +6.0% | 5,951,725 | -11.1% | 0.01% | +11.1% |
| Q4 2021 | $354,962,000 | -28.1% | 6,692,346 | -4.3% | 0.01% | -35.7% |
| Q3 2021 | $493,464,000 | +23.8% | 6,990,542 | +16.9% | 0.01% | +27.3% |
| Q2 2021 | $398,462,000 | -25.2% | 5,979,303 | +24.6% | 0.01% | -31.2% |
| Q1 2021 | $532,581,000 | -4.6% | 4,797,606 | +2.1% | 0.02% | -11.1% |
| Q4 2020 | $558,195,000 | +30.8% | 4,700,591 | -3.9% | 0.02% | +12.5% |
| Q3 2020 | $426,821,000 | -6.5% | 4,891,925 | -4.0% | 0.02% | -11.1% |
| Q2 2020 | $456,365,000 | -23.3% | 5,095,602 | -14.7% | 0.02% | -37.9% |
| Q1 2020 | $595,270,000 | -12.4% | 5,973,008 | +1.1% | 0.03% | +11.5% |
| Q4 2019 | $679,157,000 | -8.2% | 5,910,860 | +0.8% | 0.03% | -16.1% |
| Q3 2019 | $739,700,000 | +2.5% | 5,864,127 | -2.2% | 0.03% | 0.0% |
| Q2 2019 | $721,874,000 | +29.2% | 5,998,615 | -6.1% | 0.03% | +24.0% |
| Q1 2019 | $558,580,000 | -7.4% | 6,385,237 | +5.9% | 0.02% | -16.7% |
| Q4 2018 | $602,982,000 | -11.3% | 6,026,806 | +1.6% | 0.03% | +3.4% |
| Q3 2018 | $679,909,000 | +26.2% | 5,933,912 | -1.2% | 0.03% | +16.0% |
| Q2 2018 | $538,843,000 | +6.4% | 6,008,493 | -13.2% | 0.02% | +4.2% |
| Q1 2018 | $506,627,000 | +30.8% | 6,924,926 | +3.8% | 0.02% | +33.3% |
| Q4 2017 | $387,452,000 | +34.0% | 6,670,988 | +3.5% | 0.02% | +20.0% |
| Q3 2017 | $289,225,000 | +17.1% | 6,445,828 | +3.0% | 0.02% | +15.4% |
| Q2 2017 | $247,036,000 | -3.2% | 6,255,678 | -0.5% | 0.01% | -7.1% |
| Q1 2017 | $255,175,000 | +49256.9% | 6,289,728 | +48854.9% | 0.01% | +1300.0% |
| Q4 2016 | $517,000 | +2.0% | 12,848 | -8.2% | 0.00% | 0.0% |
| Q3 2016 | $507,000 | +31.7% | 14,003 | +5.4% | 0.00% | 0.0% |
| Q2 2016 | $385,000 | +215.6% | 13,291 | +279.6% | 0.00% | – |
| Q1 2016 | $122,000 | +144.0% | 3,501 | +125.7% | 0.00% | – |
| Q4 2015 | $50,000 | +35.1% | 1,551 | +35.1% | 0.00% | – |
| Q3 2015 | $37,000 | -80.8% | 1,148 | -75.3% | 0.00% | – |
| Q2 2015 | $193,000 | -20.2% | 4,655 | -13.5% | 0.00% | – |
| Q1 2015 | $242,000 | +11.5% | 5,382 | -7.3% | 0.00% | – |
| Q4 2014 | $217,000 | +12.4% | 5,804 | +4.7% | 0.00% | – |
| Q3 2014 | $193,000 | -66.0% | 5,541 | -65.5% | 0.00% | -100.0% |
| Q2 2014 | $567,000 | +190.8% | 16,059 | +169.0% | 0.00% | – |
| Q1 2014 | $195,000 | +178.6% | 5,969 | +261.1% | 0.00% | – |
| Q4 2013 | $70,000 | +2.9% | 1,653 | -2.7% | 0.00% | – |
| Q3 2013 | $68,000 | -1.4% | 1,698 | +2.5% | 0.00% | – |
| Q2 2013 | $69,000 | – | 1,656 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |